Dr. Jonathan M. Sackier
Chief Medical Officer and Managing Partner
Dr. Sackier is credited with helping to develop medical technologies including laparoscopic surgery, amniotic stem cells and the first commercial surgical robot, AESOP, brought to market by Computer Motion which was then incorporated into Intuitive Surgical’s immensely successful Da‐Vinci robotic surgery system (NASDAQ: ISRG). Dr. Sackier has advised leading family office-owned and publicly-listed multi-national companies in the pharmaceutical, device and diagnostic sectors including Karl Storz, Applied Medical, Pall Medical, Merck, Novartis and Pfizer on technology development and many aspects of healthcare. Dr. Sackier is a member of the Board of Directors of Charlottesville, VA-based Hemoshear, Inc. Additional directorships held by Dr. Sackier include Clinvue and Rex Bionics, and he acts as Medical Counsel to the Aircraft Owners and Pilots Association (AOPA). He has served on the Board of the American College of Surgeons Foundation, the Larry King Cardiac Foundation, First Star, Steppenwolf, Adenosine Therapeutics, and both founded and funded the Washington Institute of Surgical Endoscopy.
Dr. Sackier speaks internationally to lay and professional audiences on technology development and transfer, and healthcare. He loves teaching and has published extensively (7 books and over 120 articles) and serves in multiple hospital and medical society leadership roles. He is a frequent commentator in the media (television, radio and print in the US, Europe and Australasia).